AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10341322 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin and lansoprazol (double-blind placebo-controlled crossover study)
Number of subjects: 46
Study 10341322 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 46
Study 7499109 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate 22.5 mg/m2 every 6 hours
Number of subjects: 19
Study 7499109 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate 30 mg/m2 every 6 hours
Number of subjects: 19
Study 7499109 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate (various doses)
Number of subjects: 19
Study 1775522 — intervention group
Group type: EXPERIMENTAL
Intervention: Minaprine 200 mg per day
Number of subjects: 112
Study 1775522 — intervention group
Group type: EXPERIMENTAL
Intervention: Minaprine 300 mg per day
Number of subjects: 112
Study 1775522 — intervention group
Group type: COMPARATOR
Intervention: Imipramine 150 mg per day
Number of subjects: 112
Study 6924676 — intervention group
Group type: EXPERIMENTAL
Intervention: Community psychiatric nursing
Number of subjects: 0
Study 6924676 — intervention group
Group type: COMPARATOR
Intervention: Out-patient psychiatrist follow-up
Number of subjects: 0
Study 31940222 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR (Anterior Cruciate Ligament Reconstruction)
Number of subjects: 618
Study 31940222 — intervention group
Group type: COMPARATOR
Intervention: ACLR + LET (Lateral Extra-articular Tenodesis)
Number of subjects: 618
Study 31940222 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR
Number of subjects: 618
Study 31940222 — intervention group
Group type: COMPARATOR
Intervention: ACLR + LET
Number of subjects: 618
Study 31940222 — intervention group
Group type: COMPARATOR
Intervention: ACLR and ACLR + LET
Number of subjects: 618
Study 27830357 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (10,000 U/kg before anesthesia and 5000 U/kg daily on postoperative days 1 to 3)
Number of subjects: 80
Study 27830357 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin
Number of subjects: 80
Study 27830357 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 80
Study 25837879 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐Adjusting File (SAF)
Number of subjects: 70
Study 25837879 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive ultrasonic irrigation (PUI)
Number of subjects: 70
Study 25837879 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional syringe irrigation (CSI)
Number of subjects: 70
Study 25837879 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoActivator (EA)
Number of subjects: 70
Study 25837879 — intervention group
Group type: COMPARATOR
Intervention: Negative control group (5 teeth)
Number of subjects: 70
Study 25837879 — intervention group
Group type: COMPARATOR
Intervention: Positive control group (5 teeth)
Number of subjects: 70
Study 23793338 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablative full-face resurfacing using short-pulsed and dual-mode Er:YAG laser
Number of subjects: 22
Study 21104251 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stocking (CS) above the knee exerting 18 mmHg for 1 week (day and night)
Number of subjects: 57
Study 21104251 — intervention group
Group type: COMPARATOR
Intervention: Intermittent pneumatic compression (IPC) on the foot for 1 week (at night)
Number of subjects: 57
Study 21104251 — intervention group
Group type: COMPARATOR
Intervention: Comparison of CS vs IPC
Number of subjects: 57
Study 19694636 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (100 mg, n = 74)
Number of subjects: 210
Study 19694636 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (50 mg, n = 69)
Number of subjects: 210
Study 19694636 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 67)
Number of subjects: 210
Study 17445350 — intervention group
Group type: EXPERIMENTAL
Intervention: Arachidonate-enriched TAG supplementation (838 mg ARA/d for 2 weeks)
Number of subjects: 24
Study 17445350 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (dietary intakes of arachidonic acid 179 (se13) mg/d)
Number of subjects: 24
Study 17445350 — intervention group
Group type: EXPERIMENTAL
Intervention: Arachidonate-enriched TAG supplementation
Number of subjects: 24
Study 15451546 — intervention group
Group type: EXPERIMENTAL
Intervention: Deramciclane 30 mg tablet administered after a high-fat meal
Number of subjects: 18
Study 15451546 — intervention group
Group type: COMPARATOR
Intervention: Deramciclane 30 mg tablet administered after an overnight fast
Number of subjects: 18
Study 11437029 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial pacing at maximum rate of 120/minute
Number of subjects: 55
Study 9728840 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position during CSE induction
Number of subjects: 22
Study 9728840 — intervention group
Group type: COMPARATOR
Intervention: Lateral recumbent position during CSE induction
Number of subjects: 22
Study 8070502 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 24
Study 8070502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 3046297 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole rice
Number of subjects: 18
Study 3046297 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended rice
Number of subjects: 18
Study 3046297 — intervention group
Group type: COMPARATOR
Intervention: Whole potato
Number of subjects: 18
Study 3046297 — intervention group
Group type: COMPARATOR
Intervention: Blended potato
Number of subjects: 18
Study 30072135 — intervention group
Group type: EXPERIMENTAL
Intervention: PACRR scale (19-item scale) administered to physicians
Number of subjects: 333
Study 27556348 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary verapamil
Number of subjects: 60
Study 27556348 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside
Number of subjects: 60
Study 27556348 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study 25641045 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine, a second-generation antihistamine
Number of subjects: 0
Study 25641045 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 24228847 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day vitamin C for 3 months (group 1)
Number of subjects: 100
Study 24228847 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day vitamin C for 3 months (group 2)
Number of subjects: 100
Study 24228847 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (both groups)
Number of subjects: 100
Study 24228847 — intervention group
Group type: COMPARATOR
Intervention: No vitamin C supplementation (group 2)
Number of subjects: 100
Study 21864352 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-operative treatment with a sling
Number of subjects: 350
Study 21864352 — intervention group
Group type: COMPARATOR
Intervention: Plate fixation
Number of subjects: 350
Study 20713675 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether and lumefantrine
Number of subjects: 50
Study 20713675 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 50
Study 20713675 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumefantrine
Number of subjects: 50
Study 20713675 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether and dihydroartemisinin
Number of subjects: 50
Study 17444040 — intervention group
Group type: EXPERIMENTAL
Intervention: KS‐3Ai group
Number of subjects: 88
Study 17444040 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ group
Number of subjects: 88
Study 17444040 — intervention group
Group type: COMPARATOR
Intervention: AcrySof Natural group
Number of subjects: 88
Study 17444040 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ and KS‐3Ai groups
Number of subjects: 88
Study 16319603 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive acid-suppressive therapy for 4 months
Number of subjects: 72
Study 16319603 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication
Number of subjects: 72
Study 12146728 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtration strategies II-IV (with leukocyte filtration)
Number of subjects: 80
Study 12146728 — intervention group
Group type: COMPARATOR
Intervention: Control group I (without leukocyte filtration)
Number of subjects: 80
Study 10214759 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta-1b
Number of subjects: 59
Study 8929247 — intervention group
Group type: EXPERIMENTAL
Intervention: Myrin tablets (300 mg rifampicin, 150 mg isoniazid, 600 mg ethambutol HCl)
Number of subjects: 20
Study 8929247 — intervention group
Group type: COMPARATOR
Intervention: Reference (300 mg rifampicin, 200 mg isoniazid, 600 mg ethambutol HCl)
Number of subjects: 20
Study 1964020 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar gum (31.7 g per day for 6 months)
Number of subjects: 0
Study 1964020 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble gums (average of 19.5 g of added fiber per day for 4 weeks)
Number of subjects: 0
Study 1964020 — intervention group
Group type: COMPARATOR
Intervention: Low fiber diet
Number of subjects: 0
Study 1964020 — intervention group
Group type: COMPARATOR
Intervention: Diet with cellulose (insoluble fiber)
Number of subjects: 0
Study 1964020 — intervention group
Group type: COMPARATOR
Intervention: Carboxymethylcellulose gum, karaya gum, locust bean gum (soluble fibers)
Number of subjects: 0
Study 88343 — intervention group
Group type: EXPERIMENTAL
Intervention: 50%‐letters condition (letters trials)
Number of subjects: 50
Study 88343 — intervention group
Group type: EXPERIMENTAL
Intervention: 50%‐letters condition (no letters trials)
Number of subjects: 50
Study 88343 — intervention group
Group type: COMPARATOR
Intervention: Control trials
Number of subjects: 50
Study 31121250 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish version of the Hospital Anxiety and Depression Scale (HADS)
Number of subjects: 242
Study 29039153 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-shot supraclavicular block (GSCB)
Number of subjects: 50
Study 29039153 — intervention group
Group type: COMPARATOR
Intervention: Single-shot interscalene block (GISB)
Number of subjects: 50
Study 26547503 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c screening
Number of subjects: 6030
Study 26547503 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step screening approach
Number of subjects: 6030
Study 23159524 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg BUP
Number of subjects: 300
Study 23159524 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg BUP
Number of subjects: 300
Study 23159524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 21531237 — intervention group
Group type: EXPERIMENTAL
Intervention: Home blood pressure monitoring (3 times per week)
Number of subjects: 634
Study 21531237 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored behavioral self-management intervention administered via telephone by a nurse every other month
Number of subjects: 634
Study 21531237 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of home blood pressure monitoring and tailored behavioral self-management intervention
Number of subjects: 634
Study 21531237 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 634
Study 19704064 — intervention group
Group type: EXPERIMENTAL
Intervention: Six courses of paclitaxel 175 mg/m² every 3 weeks (maintenance)
Number of subjects: 200
Study 19704064 — intervention group
Group type: COMPARATOR
Intervention: Observation (control)
Number of subjects: 200
Study 17075665 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrode placement at the left mid-axillary line at the fourth and fifth intercostal spaces (CO2)
Number of subjects: 30
Study 17075665 — intervention group
Group type: COMPARATOR
Intervention: Recommended electrode placements (CO1 and CO3)
Number of subjects: 30
Study 15246901 — intervention group
Group type: COMPARATOR
Intervention: Polymer-free Paclitaxel stents (0.2 to 3.1 microg paclitaxel/mm²)
Number of subjects: 326
Study 15246901 — intervention group
Group type: COMPARATOR
Intervention: Polymer-free Paclitaxel stents (0.7 to 3.1 microg/mm²)
Number of subjects: 326
Study 11758844 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin 2.0-2.5 mg/kg twice daily
Number of subjects: 54
Study 11758844 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin 4.0-5.0 mg/kg once daily
Number of subjects: 54
Study 9413851 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated circuits (group H)
Number of subjects: 24
Study 9413851 — intervention group
Group type: COMPARATOR
Intervention: Uncoated circuits (group C)
Number of subjects: 24
Study 8484654 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobunolol
Number of subjects: 115
Study 8484654 — intervention group
Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 115
Study 3610515 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical benzydamine
Number of subjects: 32
Study 3610515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 29040231 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion through an OnQ pump
Number of subjects: 50
Study 29040231 — intervention group
Group type: COMPARATOR
Intervention: Single-shot nerve block (SSB group)
Number of subjects: 50
Study 27207739 — intervention group
Group type: EXPERIMENTAL
Intervention: CQ‐01 (a guar gum‐based hydrogel impregnated with peppermint oil, menthol, and methyl salicylate)
Number of subjects: 74
Study 27207739 — intervention group
Group type: COMPARATOR
Intervention: Gel control
Number of subjects: 74
Study 27207739 — intervention group
Group type: COMPARATOR
Intervention: Gauze negative control
Number of subjects: 74
Study 24887229 — intervention group
Group type: EXPERIMENTAL
Intervention: Need as a motivation for blood donation
Number of subjects: 800
Study 24887229 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety concerns
Number of subjects: 800
Study 24887229 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of donating blood
Number of subjects: 800
Study 24887229 — intervention group
Group type: EXPERIMENTAL
Intervention: Active blood donors
Number of subjects: 800
Study 24887229 — intervention group
Group type: EXPERIMENTAL
Intervention: Occasional blood donors
Number of subjects: 800
Study 24887229 — intervention group
Group type: EXPERIMENTAL
Intervention: Rare blood donors
Number of subjects: 800
Study 24887229 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-donors
Number of subjects: 800
Study 24887229 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes towards intention to donate
Number of subjects: 800
Study 24887229 — intervention group
Group type: EXPERIMENTAL
Intervention: Indifference towards blood donation
Number of subjects: 800
Study 22178630 — intervention group
Group type: EXPERIMENTAL
Intervention: Compressive fracture strength test
Number of subjects: 40
Study 22178630 — intervention group
Group type: COMPARATOR
Intervention: Three point flexure test
Number of subjects: 40
Study 22178630 — intervention group
Group type: COMPARATOR
Intervention: Biaxial flexure test
Number of subjects: 40
Study 22178630 — intervention group
Group type: COMPARATOR
Intervention: Coefficient of Variation (CoV) values
Number of subjects: 40
Study 20646375 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic Focus (F)
Number of subjects: 93
Study 20646375 — intervention group
Group type: COMPARATOR
Intervention: Traditional technique (C)
Number of subjects: 93
Study 20646375 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 93
Study 17640421 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato juice without vitamin C (L)
Number of subjects: 0
Study 17640421 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato juice with vitamin C (LC)
Number of subjects: 0
Study 15219043 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium enoxaparin
Number of subjects: 2
Study 15219043 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 2
Study 11112678 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cefixime
Number of subjects: 200
Study 11112678 — intervention group
Group type: COMPARATOR
Intervention: Intravenous antibiotics
Number of subjects: 200
Study 9689265 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% sevoflurane
Number of subjects: 20
Study 9689265 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% sevoflurane
Number of subjects: 20
Study 9689265 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% and 2.5% sevoflurane
Number of subjects: 20
Study 8270972 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal clonidine
Number of subjects: 0
Study 2511726 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% halothane anaesthesia
Number of subjects: 20
Study 2511726 — intervention group
Group type: EXPERIMENTAL
Intervention: neurolept anaesthesia
Number of subjects: 20
Study 831435 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunoileal bypass operation
Number of subjects: 138
Study 831435 — intervention group
Group type: COMPARATOR
Intervention: Control (unoperated)
Number of subjects: 138
Study 31621668 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Group D) 1 μg/kg
Number of subjects: 90
Study 31621668 — intervention group
Group type: COMPARATOR
Intervention: Esmolol (Group E) 2 mg/kg
Number of subjects: 90
Study 31621668 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of dexmedetomidine and esmolol (Group DE) 0.5 μg/kg dexmedetomidine with 1 mg/kg esmolol
Number of subjects: 90
Study 28344112 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg semaglutide
Number of subjects: 1089
Study 28344112 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg semaglutide
Number of subjects: 1089
Study 28344112 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 1089
Study 25939908 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 insufflation (group A)
Number of subjects: 300
Study 25939908 — intervention group
Group type: COMPARATOR
Intervention: No CO2 insufflation (group B)
Number of subjects: 300
Study 22691110 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled atropine sulfate via MicroDose Dry-Powder Inhaler (DPIA), 1.95 mg (5 doses × 0.4 mg per dose delivered over 12 min)
Number of subjects: 17
Study 22691110 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (IM) atropine via auto-injector (AUTO), 2 mg
Number of subjects: 17
Study 21144780 — intervention group
Group type: EXPERIMENTAL
Intervention: Toltrazuril (T)
Number of subjects: 120
Study 21144780 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclazuril (D)
Number of subjects: 120
Study 21144780 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 120
Study 18590586 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin (10 g/d) for 16 days
Number of subjects: 12
Study 16483083 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based cleanliness campaign
Number of subjects: 0
Study 14706720 — intervention group
Group type: EXPERIMENTAL
Intervention: Kava extract WS 1490
Number of subjects: 61
Study 14706720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 11230611 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% permethrin creme rinse (1% PER)
Number of subjects: 115
Study 11230611 — intervention group
Group type: EXPERIMENTAL
Intervention: oral trimethoprim/sulfamethoxazole (TMP/SMX)
Number of subjects: 115
Study 11230611 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 1% PER and TMP/SMX
Number of subjects: 115
Study 9149675 — intervention group
Group type: EXPERIMENTAL
Intervention: CO inhalation (1000 ppm for first 30 minutes, 100 ppm for last 30 minutes)
Number of subjects: 10
Study 9149675 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (room air inhalation)
Number of subjects: 10
Study 7957468 — intervention group
Group type: EXPERIMENTAL
Intervention: Uro-Vaxom (UV)
Number of subjects: 112
Study 7957468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 3579364 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon monoxide (CO) exposure (100 ppm, COHb average = 3.8 +/- 0.1%)
Number of subjects: 30
Study 3579364 — intervention group
Group type: COMPARATOR
Intervention: Air exposure (COHb = 1.5 +/- 0.05%)
Number of subjects: 30
Study 29477015 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad mood induction
Number of subjects: 0
Study 29477015 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive mood induction
Number of subjects: 0
Study 29477015 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative emotion differentiation
Number of subjects: 0
Study 29477015 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion regulation difficulties
Number of subjects: 0
Study 29477015 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive emotion differentiation
Number of subjects: 0
Study 27756884 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT) in stage II patients with high E2F score
Number of subjects: 0
Study 27756884 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT) in stage II patients with low E2F score
Number of subjects: 0
Study 27756884 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients with low E2F score
Number of subjects: 0
Study 27756884 — intervention group
Group type: EXPERIMENTAL
Intervention: E2F score as a prognostic biomarker
Number of subjects: 0
Study 27756884 — intervention group
Group type: EXPERIMENTAL
Intervention: E2F score as a predictive biomarker
Number of subjects: 0
Study 27756884 — intervention group
Group type: EXPERIMENTAL
Intervention: E2F score in stage I patients
Number of subjects: 0
Study 25539792 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary perfusion with oxygenated blood or Custodiol™ HTK solution
Number of subjects: 90
Study 25539792 — intervention group
Group type: COMPARATOR
Intervention: No pulmonary perfusion
Number of subjects: 90
Study 23945405 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/day soy isoflavone supplementation
Number of subjects: 182
Study 23945405 — intervention group
Group type: COMPARATOR
Intervention: 500 mg calcium carbonate (Control)
Number of subjects: 182
Study 20578658 — intervention group
Group type: EXPERIMENTAL
Intervention: CCLAD (computer-controlled local anesthetic delivery system)
Number of subjects: 40
Study 20578658 — intervention group
Group type: COMPARATOR
Intervention: Traditional buccal/palatal injections
Number of subjects: 40